503A Category 2
FDA designation for substances nominated for compounding under Section 503A but flagged with significant safety concerns — effectively do-not-compound pending review.
FDA designation for substances nominated for compounding under Section 503A but flagged with significant safety concerns — effectively do-not-compound pending review.